The First Affiliated Hospital Of Xiamen University

This early-phase trial tests whether transplanting gut bacteria from young donors (via capsules or a tube) can help immunotherapy work better in people with a type of advanced colorectal cancer that usually doesn't respond to immunotherapy. Ten patients who have already tried sta…

This early-stage trial tests a combination of two drugs—peginterferon alfa-2b and an anti-PD-1 antibody—in about 60 people with advanced or metastatic solid tumors who have no standard treatment options left. The main goal is to find a safe dose and check for side effects. Resear…

This early-phase study is testing whether combining two targeted drugs (pyrotinib and dalpiciclib) with standard hormone therapy can shrink tumors in people with HR+HER2 low breast cancer before they have surgery. The study plans to enroll 33 patients with locally advanced diseas…

This study looks at whether semaglutide (a diabetes drug that lowers blood sugar and helps with weight loss) affects bone density and fracture risk in people with type 2 diabetes. About 150 adults aged 50–75 will get either semaglutide plus metformin or metformin alone for 12 mon…

This observational study will test whether two new types of PET/CT scans can more accurately stage nasopharyngeal carcinoma and predict how well patients respond to immunotherapy before treatment. About 732 participants aged 18-70 with newly diagnosed, untreated cancer will recei…